Aperture Venture Partners

Venture Capital Active United States
Last updated 2026-06-18
Portfolio
2
in our dataset
Rounds participated
2
Rounds led
0
Rounds' value
$119.0M
total disclosed, rounds participated
Stages
—

Portfolio · 2

V-Wave
Miniature Shunt for Treating Congestive Heart Failure
1 round $98.0M committed Latest: 2020-09
Venus Concept
RF-based Technology for the Medical Aesthetics Market
1 round $21.0M committed Latest: 2019-11

Investment activity

2 portfolio exits on record.

Portfolio by sector

Health Tech & Life Sciences2

Q&A

What is Aperture Venture Partners' most recent notable exit?
Aperture Venture Partners saw the acquisition of its portfolio company V-Wave by Johnson & Johnson in August 2024 for $600M.
Which sectors does Aperture Venture Partners primarily focus on for investments?
Aperture Venture Partners has a clear focus on the Health Tech & Life Sciences sector, with all of its recorded portfolio companies and exits falling within this area.
Can you name a key public exit for Aperture Venture Partners?
Aperture Venture Partners had a public exit with Venus Concept, which went public on NASDAQ in November 2019.
What is the most recent investment stage Aperture Venture Partners participated in?
Aperture Venture Partners participated in a PIPE round, which is its most recent recorded investment stage.
How many portfolio companies does Aperture Venture Partners have in the Health Tech & Life Sciences sector?
Aperture Venture Partners has two portfolio companies in the Health Tech & Life Sciences sector, V-Wave and Venus Concept.